The Express Gene™ Comprehensive Pharmacogenomics (PGX) test provides personalized insights into your drug response and compatibility based on your genetic profile. By analyzing targeted SNPs in 38 key genes related to drug metabolism, response, and potential risks, this test empowers you and your healthcare provider to make informed decisions about your medication regimen.
Receive personalized medication recommendations based on your individual genetic makeup, ensuring optimal treatment outcomes.
Mitigate the risk of adverse drug reactions and side effects by identifying medications that may not be compatible with your genetic profile.
Determine the most effective dosage for your medications, minimizing the need for trial and error in finding the right balance.
Explore the Genetic Markers Included in Our Cancer Genetic Testing Panel
ACP5, ADA2, ADAM17, ADAR, AP1S3, ASAH1, CARD14, COPA, DDX58, ELANE, HAX1, HTR1A, IFIH1, IL10RA, IL10RB, IL1RN, IL36RN, ISG15, LPIN2, MEFV, MVK, NLRC4, NLRP1, NLRP12, NLRP3, NOD2, OTULIN, PIK3CD, PIK3R1, PLCG2, POLA1, POMP, PRG4, PRKCD, PSENEN, PSMA3, PSMB4, PSMB8, PSMG2, PSTPIP1, RBCK1, RIPK1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, SH3BP2, SLC29A3, TMEM173, TNFAIP3, TNFRSF11A, TNFRSF1A, TREX1, TRNT1, USP18, WDR1
© 2024 ExpressGene. All rights reserved. Unless otherwise indicated, all product names, service names, and logos featured on this website are trademarks owned by ExpressGene, its subsidiaries, or its affiliates. Any use of ExpressGene trademarks, trade names, or trade dress on this website must be authorized in writing by ExpressGene, except for the purpose of identifying ExpressGene’s products or services.